Homepage

CURRENTLY IN NEXARS

Groundbreaking research in the field of exosomes – NEXARS brings revolutionary advancements in exosome medicine

EXOSOMES: Key carriers of intracellular communication

Building on our latest research and publications in prestigious scientific journals, we are delving deeper into the role of exosomes — small membrane vesicles — in intercellular communication. These nanoparticles play a vital part in the transfer of proteins, lipids and nucleic acids between cells, thereby influencing physiological and pathological processes. The ability to understand and manipulate exosomes opens up new possibilities in regenerative medicine, diagnostics and targeted therapy for various diseases, including cancer and neurodegenerative disorders.

Exosomes also show great potential as biomarkers for the early detection and monitoring of tumour progression.

Key areas of exosome medicine:

REGENERATIVE MEDICINE: exosomes as carriers of signalling molecules for tissue repair and anti-inflammatory effects.
DIAGNOSTICS: the potential of exosomes as biomarkers for early detection and monitoring.
NEURODEGENERATIVE DISEASES: use of exosomes for delivering therapeutic agents across the blood–brain barrier.
TARGETED THERAPY: development of innovative exosome-based therapies for precise drug delivery.

Refer to our publication

LEARN MORE

The new dietary supplement IMUNOCOMPLEX 2020+, developed primarily to support long-term training of mucosal immunity, has been awarded the prestigious “BEST BIOTECHNOLOGY PRODUCT AWARD”

Mucous membranes are the entry points for infections and form the body's natural barrier when it comes into contact with the external environment. These membranes can be found in the respiratory, digestive, urogenital tracts, and the eyes. In today's modern "sterile" world, we lack microbial stimuli, leading to reduced immune resistance.

Immune stimulation and modulation of excessive inflammation are achieved through microbial signals using original NEXARS strains of human probiotics and microscopic fungi (see GenBank link).

The award-winning product was successfully validated in practice during the 2020–2022 pandemic.

This achievement in 2022 is confirmed by a statement from Mgr. Jiří Prokop, Ph.D., Head of Health Services and Ergonomics at ŠKODA AUTO a.s., regarding the improved IMUNOCOMPLEX 2020+ product:

'We evaluated this programme as effective because it helped us reduce the impact of the pandemic, achieve high employee compliance and provide a basis for the long-term, cost-effective management of the infectious disease, SARS-CoV-2.'

Best Biotechnology Product Award

LEARN MORE

Applied research
and experimental development

Investing to research and development of bio- and nanotechnologies is our priority, because only the rapid implementation of the nowadays knowledge and constant innovation will ensure our future.

The breaking goals are consulted with the company’s strategic advisory board, the Scientific Council composed of leading experts in Czech science.

MORE ABOUT OUR RESEARCH

Guaranteed information
with a professional supervision

Health is indisputably the most valuable aspect of our lives. Therefore, our website provides only verified information that has undergone professional revisions.

MORE ABOUT EDUCATION

Protection and support
for your health

We put our research results into practice

– we produce original raw materials, which can be further re-formulated so that the final products are bioavailable to a human body. We want to give everyone the opportunity to answer the difference under what conditions our body is built and the conditions in which we live daily.

OUR PRODUCTS

INNOVATION
AND ORIGINALITY

We are a Czech innovative research organization investing into research, education and rapid implementation of results to everyday lives with an emphasis on progressive (high-tech) technologies.

MORE ABOUT US